Academic Scientific JournalsPrevalence of self-reported premenstrual psychological symptoms during the COVID-19 quarantine: An exploratory cross-sectional study
Keywords:
COVID-19, premenstrual symptoms, gender medicineAbstract
Background:
Premenstrual dysphoric disorder (PMDD) is a severe mood-related condition affecting 3-8% of women of reproductive age. It is characterized by affective, cognitive, and physical symptoms that occur during the luteal phase of the menstrual cycle and resolve shortly after menstruation.
Participants and procedure:
This study explored the prevalence of self-reported psychological symptoms consistent with PMDD criteria among Italian women during the COVID-19 quarantine. We conducted a cross-sectional, anonymous online survey, which included items based on DSM-5 symptom criteria, in May 2020, using Google Forms.
Results:
A total of 109 women were enrolled; 77% of the sample reported suffering from premenstrual symptoms. Approximately 36.7% of respondents reported experiencing at least five symptoms, including one core affective symptom.
Conclusions:
The results of this study are not consistent with the existing literature. These findings highlight the need for greater attention to women’s mental health during periods of heightened stress.
Downloads
References
American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). APA Publishing.
Gingnell, M., Bannbers, E., Wikström, J., Fredrikson, M., & Sundström-Poromaa, I. (2013). Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli. European Neuropsychopharmacology, 23, 1474–1483. https://doi.org/10.1016/j.euroneuro.2013.08.002
Halbreich, U., Borenstein, J., Pearlstein, T., & Kahn, L. S. (2003). The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology, 28, 1–23. https://doi.org/10.1016/S0306-4530(03)00098-2
Hantsoo, L., & Epperson, C. N. (2015). Premenstrual dysphoric disorder: Epidemiology and treatment. Current Psychiatry Reports, 17, 87. https://doi.org/10.1007/s11920-015-0628-3
Hantsoo, L., Rangaswamy, S., Voegtline, K., Salimgaraev, R., Zhaunova, L., & Payne, J. L. (2022). Premenstrual symptoms across the lifespan in an international sample: Data from a mobile application. Archives of Women’s Mental Health, 25, 903–910. https://doi.org/10.1007/s00737-022-01261-5
Hartlage, S. A., Freels, S., Gotman, N., & Yonkers, K. (2012). Criteria for premenstrual dysphoric disorder: Secondary analyses of relevant data sets. Archives of General Psychiatry, 69, 300–305. https://doi.org/10.1001/archgenpsychiatry.2011.1368
Huo, L., Straub, R. E., Roca, C., Schmidt, P. J., Shi, K., Vakkalanka, R., Weinberger, D. R., & Rubinow, D. R. (2007). Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biological Psychiatry, 62, 925–933. https://doi.org/10.1016/j.biopsych.2006.12.019
Inoue, Y., Terao, T., Iwata, N., Okamoto, K., Kojima, H., Okamoto, T., Yoshimura, R., & Nakamura, J. (2007). Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: Findings from neuroendocrine challenge tests. Psychopharmacology, 190, 213–219. https://doi.org/10.1007/s00213-006-0607-9
Mason-Hohl, E. (1940). The diseases of women by Trotula of Salerno: a translation of Passionibus Mulierum Curandorum. Ward Ritchie Press.
Özberk, H., Bilgiç, D., Arı, F. G., Özeren, M., & Başoğlu, M. (2024). COVID-19 phobia, personality traits and menopausal symptoms in women in the climacteric period. Przegląd Menopauzalny/Menopause Review, 23, 133–139. https://doi.org/10.5114/pm.2024.143468
Polese, D., Costanzi, F., Bianchi, P., Frega, A., Bellati, F., De Marco, M. P., Parisi, P., Bruni, O., Caserta, D., & Cozza, G. (2024). The impact of COVID-19 on menstrual cycle’s alterations, in relation to depression and sleep disturbances: a prospective observational study in a population of medical students. BMC Women’s Health, 24, 130. https://doi.org/10.1186/s12905-024-02971-x
Protopopescu, X., Tuescher, O., Pan, H., Epstein, J., Root, J., Chang, L., Altemus, M., Polanecsky, M., McEwen, B., Stern, E., & Silbersweig, D. (2008). Toward a functional neuroanatomy of premenstrual dysphoric disorder. Journal of Affective Disorders, 108, 87–94. https://doi.org/10.1016/j.jad.2007.09.015
World Health Organization (2019). International Classification of Diseases, 11th Revision (ICD-11). Retrieved from https://icd.who.int/en/
Yonkers, K. A., O’Brien, P. M. S., & Eriksson, E. (2008). Premenstrual syndrome. The Lancet, 371, 1200–1210. https://doi.org/10.1016/S0140-6736(08)60527-9
